These data led to the conclusion that SOAT-mediated E1S uptake contributes to the overall cell proliferation of hormone-dependent breast cancer cells and that SOAT inhibitors have anti-proliferative potential. This evidence concerns the gene SLC10A6 and breast carcinoma.